Longitudinal Analysis of the Vaginal Microbiome
1 other identifier
observational
29
1 country
1
Brief Summary
This is a longitudinal, observational study with the goal of understanding vaginal microbiome changes both within a single day and across a menstrual cycle. The study will be composed of at least 10 women that have regular menstrual cycles and are 18 years of age or older. This study is direct to participant and will NOT utilize clinical sites.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2022
CompletedFirst Posted
Study publicly available on registry
May 20, 2022
CompletedStudy Start
First participant enrolled
July 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 20, 2023
CompletedDecember 12, 2023
December 1, 2023
1.1 years
May 16, 2022
December 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Identification of vaginal microbial taxonomy
A vaginal metatranscriptomic test will be used to analyze the vaginal microbiome taxonomy
1 year
Identification of vaginal microbial functions
A vaginal metatranscriptomic test will be used to analyze the vaginal microbiome functions
1 year
Eligibility Criteria
At least 10 women with regular menstrual cycles age 18 or older that meet the inclusion criteria.
You may qualify if:
- Biological sex is female
- Willing to collect own vaginal samples
- Willing to answer health questions
- Experience menstrual cycles regularly (a monthly cycle)
You may not qualify if:
- Pregnant
- Antibiotic use in the past 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Viomelead
Study Sites (1)
Viome Life Sciences
Bothell, Washington, 98011, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Momchilo Vuyisich
Viome
- PRINCIPAL INVESTIGATOR
Guruduth Banavar
Viome
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 16, 2022
First Posted
May 20, 2022
Study Start
July 7, 2022
Primary Completion
August 20, 2023
Study Completion
August 20, 2023
Last Updated
December 12, 2023
Record last verified: 2023-12